Virax Biolabs, is a company developing a game-changing immunology platform based around T-Cell testing called Virax ... Scientists at Codagenix have developed a synthetic biology platform that combines live-attenuated virus design with ... Many Americans continue to face symptoms of Long COVID. After testing negative, inflammation caused by the virus ... The height of the COVID-19 pandemic impacted all sectors of health care, especially cardiology. In this interview, ... September is Sepsis Awareness Month. Sepsis, which is a potentially deadly condition that stems when the body's response ... Accurate linking of medical records from sources, known as patient matching, plays a critical role in patient safety and ... Recent data from Premier Inc. show that drugs that have slipped into shortage as a result of COVID-19 and cracks in the ... It's been well over two years since the world forever changed due to the COVID-19 pandemic. The rapid spread of the ... Detecting sepsis is a major challenge for clinicians triaging patients arriving at an emergency department with few or ... A recent study reports that despite major changes in mask policies from the state and federal levels, people still ... A recent CDC study found that mRNA booster shots are 82% effective in protecting against COVID-19 Omicron ... Recently, Acadia Pharmaceuticals announced positive top-line results from the pivotal, Phase III LAVENDER study, which ... DocWire News spoke with Jim Joyce, Co-Founder, Chairman, and CEO of Sigyn Therapeutics, a developmental technology ... Seqirus, one of the largest influenza vaccine providers in the world, recently announced plans to accelerate the ... Recently, Eitan Medical announced that MPP Infusion Centers®, a Joint Commission-accredited ambulatory infusion ... Throughout the COVID-19 pandemic, one piece of medical equipment has featured heavily – the ventilator. The question ... A recent study assessed oncology trial enrollment trends following the first wave of the COVID-19 pandemic. This ... UK scientists at Hydroxyl Technologies have developed a new air decontamination technology that can potentially kill ... Regeneron recently presnted results from the Phase 3 pivotal trial showing REGEN‑COV™ (casirivimab with imdevimab) ... Medidata, a Dassault Systèmes company, presented a study at the 2021 ASCO Annual Meeting which assessed of the effect ...